Fiche du document
28 octobre 2020
- doi: 10.3390/pathogens9110898
- issn: 2076-0817
Ce document est lié à :
info:eu-repo/semantics/altIdentifier/doi/10.3390/pathogens9110898
Ce document est lié à :
info:eu-repo/semantics/altIdentifier/pmid/33126413
Ce document est lié à :
info:eu-repo/semantics/altIdentifier/pissn/2076-0817
Ce document est lié à :
info:eu-repo/semantics/altIdentifier/urn/urn:nbn:ch:serval-BIB_A1E0AA0786FD3
info:eu-repo/semantics/openAccess , CC BY 4.0 , https://creativecommons.org/licenses/by/4.0/
Sujets proches
Polyradiculoneuritis Landry-Guillain-Barré syndrome Landry's paralysis Acute idiopathic polyneuritis Infectious diseasesCiter ce document
S. Masmejan et al., « Zika Virus. », Serveur académique Lausannois, ID : 10.3390/pathogens9110898
Métriques
Partage / Export
Résumé
Zika virus (ZIKV), a neurotropic single-stranded RNA flavivirus, remains an important cause of congenital infection, fetal microcephaly, and Guillain-Barré syndrome in populations where ZIKV has adapted to a nexus involving the Aedes mosquitoes and humans. To date, outbreaks of ZIKV have occurred in Africa, Southeast Asia, the Pacific islands, the Americas, and the Caribbean. Emerging evidence, however, suggests that the virus also has the potential to cause infections in Europe, where autochtonous transmission of the virus has been identified. This review focuses on evolving ZIKV epidemiology, modes of transmission and host-virus interactions. The clinical manifestations, diagnostic issues relating to cross-reactivity to the dengue flavivirus and concerns surrounding ZIKV infection in pregnancy are discussed. In the last section, current challenges in treatment and prevention are outlined.